Medinice has an agreement with Clairfield Partners for consultancy on among others with the commercialization of projects

Medinice has signed an agreement with Clairfield Partners LLC for consulting in the process of creating strategic partnerships, selling licenses and selling intellectual property and related technology, the company announced.

Clairfield will be responsible for identifying and selecting potential buyers and partners. This activity will include the preparation of the necessary materials and establishing contacts with global companies in the healthcare industry. Clairfield will also support Medinice in organizing the due diligence process, shaping the negotiation strategy and managing final talks related to the transaction. Medinice plans to commercialize its first project later this year, it was reported.

“Due to the global potential of our projects, we are looking forward to working with such an experienced partner, which confirms the attractiveness of the technologies we develop. We have worked hard for many years to reach this stage of development. Our most advanced project, PacePress, is in the clinical trials phase and may be the first candidate for commercialization. MiniMax and CoolCryo are also closely behind them in development. We are glad that Clairfield has recognized the potential of our company and will support us in choosing a global strategic partner, which remains our priority for this year,” said Sanjeev Choudhary, president of Medinice, quoted in the release.

Clairfield advises medium-sized companies on mergers, acquisitions and sales, and also provides additional corporate finance services, mainly in international relations.

“We are pleased to partner with Medinice and look forward to accompanying them in realizing their full potential in the interventional cardiology and cardiac surgery market,” added Clairfield International Managing Partner Crosby O’Hare.

Medinice is a Polish company with a global reach, which is a platform for solutions used in cardiology. The company develops its own projects and projects obtained from scientists from Poland and abroad. The company debuted on the main market of the Warsaw Stock Exchange in 2020.


Our privacy policy